Related Experiment Videos
[Staphylococcus aureus in the hospital milieu]
Archives De L'Institut Pasteur De Tunis
|July 1, 1992
Summary
This study analyzed 318 Staphylococcus aureus strains, finding high rates of methicillin resistance and co-resistance to macrolides and lincosamides. Pritinamicin, sulfamethoxazole-trimethoprim, and ofloxacin show promise for treating these infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Context:
- Analysis of 318 Staphylococcus aureus strains from La Rabta hospital units.
- Prevalence of isolation in surgery, intensive care, dermatology, and ENT units.
- Inclusion of various sample types: matter, blood, and intensive care materials.
Purpose:
- To determine the distribution of Staphylococcus aureus strains in clinical samples.
- To evaluate the antibiotic susceptibility patterns of isolated Staphylococcus aureus.
- To identify effective therapeutic alternatives against resistant strains.
Summary:
- A high frequency of methicillin-resistant Staphylococcus aureus (MRSA) was detected.
- Strains exhibited significant resistance to macrolide and lincosamide antibiotics (MLSB resistance).
- Gentamicin-resistant strains consistently showed co-resistance to methicillin.
Impact:
- Highlights the prevalence of multidrug-resistant Staphylococcus aureus in a hospital setting.
- Identifies specific antibiotic classes (pritinamicin, sulfamethoxazole-trimethoprim, ofloxacin) as potential treatment options.
- Informs clinical decision-making for managing Staphylococcus aureus infections, particularly MRSA.